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Self-management and integrated pulmonary care 
as an essential part of treatment of patients 
with chronic obstructive pulmonary disease
Abstract
Chronic obstructive pulmonary disease (COPD) is a common, chronic and progressive disease that is a major public health 
problem worldwide. Treatment for stable COPD relies on pharmacological and non-pharmacological procedures. Education, 
self-management interventions and personalized pulmonary rehabilitation should be part of chronic care for patients with COPD 
at all stages of their disease. 
The comprehensive care should be provided by integrated pulmonary care based on pulmonary centers and a multidisciplinary 
team to all patients with COPD. Holistic approach to the patient with COPD and his involvement in therapy and working closely 
with healthcare professionals will improve quality of life of COPD patients. It also modifies the course of the disease, prevents 
progression and may reduce the frequency of exacerbations. In this article, we present the proposed model of integrated pulmo-
nary care, structures necessary for multidisciplinary treatment and self-management intervention as essential elements in the 
treatment of patients with COPD.
Key words: chronic obstructive pulmonary disease, COPD treatment, self-management, integrated pulmonary care
Adv Respir Med. 2021; 89: 291–298
Introduction
Chronic obstructive pulmonary disease 
(COPD) is currently the 3rd leading cause of death 
in the world. It is predicted that COPD morbidity 
will increase in the coming years due to the con-
stant exposure to risk factors and the aging of the 
population [1]. The disease can be treated, and 
more importantly, we could prevent it by taking 
appropriate prophylaxis. Due to its chronic na-
ture, it also poses a significant challenge to public 
health worldwide [2].
So far, no epidemiological studies of COPD 
have been conducted in Poland, which would 
include a representative sample of the entire 
population of the country. In partial studies, 
symptoms of the disease were found in 10% of 
the respondents over 40 years of age [3]. It is esti-
mated that approximately 80% of COPD patients 
in Poland have mild or moderate illness, which 
causes delays in diagnosis and underestimates 
the actual number of cases [4]. The prognosis of 
advanced stages of COPD, often complicated by 
hypercapnic respiratory failure, is severe. Five-
year survival in this group of patients is 26–50% 
[5].
Treatment of stable COPD is based on phar-
macological (Table 1) and non-pharmacological 
management. Reduction of the disease symptoms, 
improvement of general health and exercise tol-
erance, prevention of exacerbations and disease 
progression, and thus decreased  mortality, are 
the main goals of the treatment [2, 6].
The therapeutic management is modified 
individually for each patient with particular 
emphasis on the frequency of exacerbations and 
dyspnea. The pharmacological treatment regimen 
should be personalized, and the physician should 
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also take into account possible side effects, the 
availability and cost of drugs used, comorbid-
ities, as well as preferences and the ability to 
use various devices for drug distribution to the 
respiratory tract [2, 7].
In the natural course of the disease, the so-
called exacerbations, i.e. acute episodes charac-
terized by an increase in respiratory symptoms 
above their usual daily intensity force the patient 
to change the current treatment [8]. Frequent 
exacerbations accelerate the annual decline in 
FEV and worsen the patient quality of life. They 
are also a major cause of increased mortality 
among these patients. Numerous outpatient visits 
and hospitalizations of individuals with COPD 
exacerbations significantly increase the costs of 
treatment and burden the healthcare system [9].
Patients with COPD experience much low-
er satisfaction with the treatment they receive 
compared with persons treated for advanced lung 
cancer [5]. This is probably due to the low interest 
in prognosis and therapeutic options. This may 
be due to a lack of integrated medical care and 
insufficient awareness of self-management of the 
disease [10].
The main form of non-pharmacological 
treatment to prevent disease progression is the 
identification and elimination of the exposure 
to risk factors. The most important procedure 
with proven effectiveness is smoking cessation 
[11]. In order to improve the efficiency and thus 
the quality of life of all COPD patients, physical 
activity should be encouraged according to their 
clinical status [12]. An important element of care 
is also personalized pulmonary rehabilitation 
[2, 13]. Unfortunately, the long-term effect of 
the conducted rehabilitation programs, usually 
in the form of several-week sessions, is rather 
controversial [14–16]. An alternative or a valu-
able supplement for them is the patient’s active 
participation in treatment plan, going beyond the 
rehabilitation program period.
Education and self-management motivation 
provided by healthcare professionals should be 
the primary focus of continuing care for COPD 
patients. The idea of intervening in self-control 
is to involve patients in the treatment process as 
early as possible in order to positively adjust their 
health behaviors and develop the ability to better 
cope with the disease on a daily basis [2, 17]. As 
a result, it may modify the course of the disease 
and reduce the frequency of exacerbations.
Integrated medical care for patients 
with COPD
Comprehensive care for patients with COPD 
in Poland is still insufficient. This is due to the 
imperfections of the current health care system, 
its limited financing, the lack of understanding 
of the importance of the patient complicity in 
holistic therapy from day one, and not only in 
alleviating the effects of respiratory failure. During 
recent years there were many improvements in 
Polish pulmonary care of patients with advanced 
COPD. A long-term oxygen therapy and non-inva-
sive ventilation are more common and available 
nowadays. We also observe a better cooperation of 
respiratory physicians with palliative care special-
ists. However, there is still no full, comprehensive 
care for patients with mild and moderate disease. 
Table 1. Initial pharmacological treatment of COPD according to GOLD reports ([2] self modificated)
Initial COPD drug therapy depending on symptoms and risk of exacerbation
Group Treatment Comments
A. Mild symptoms and low risk  
of exacerbations
A bronchodilator In patients with sporadic dyspnea,  
it may be a short-acting drug, in others — a long-acting 
drug. Treatment should only be continued if it causes 
improvement
B. Severe symptoms and low risk  
of exacerbations
A long-acting bronchodilator  
(LABA or LAMA)
In patients with severe symptoms, 
it may be considered LABA + LAMA
C. Mild symptoms and high risk  
of exacerbations
LAMA
D. Severe symptoms and high 
risk of exacerbations
LAMA or LAMA + LABA  
(with severe symptoms) or LABA + ICS  
(when blood eosinophil count > 300/µL)ª
When bronchodilators are used alone, 
the treatment is usually initiated with LAMA, except 
in patients with severe symptoms
ªIn optimally treated patients (LAMA + LABA + ICS) with recurrent exacerbations, addition of roflumilast in patients with chronic bronchitis and FEV1 < 50% or 
azithromycin in ex-smokers should be considered; COPD — chronic obstructive pulmonary disease; ICS — inhaled corticosteroids; LABA —  long-acting β2-agonists; 
LAMA — long acting muscarinic antagonists
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Integrated care models recommended and effec-
tive for chronic diseases, such as diabetes, should 
also be used in patients with lung diseases. The 
role of comprehensive care including medical 
assistance, in accordance with the applicable 
standards, and supervision treatment, support for 
patients and their families at home is emphasized 
by all physicians. The recommendations of the 
Polish Society of Lung Diseases regarding the or-
ganization of integrated pulmonary care take into 
account almost exclusively the aspect of palliative 
care in the end stage of advanced respiratory fail-
ure in advanced COPD [18].
Identifying essential components, which can 
bring measurable benefits, is crucial for  integrat-
ed medical care of COPD patients. Casas et al. in 
an international study conducted in Belgium and 
the Netherlands on patients with severe COPD 
requiring hospitalization due to exacerbations, 
have confirmed that integrated care after dis-
charge from hospital resulted in a lower number 
of exacerbations in a one-year follow-up [19].
In their study, the essence of the integrated 
program was based on the following four basic 
elements:
— detailed assessment of the patient’s condition 
including determination of the severity of the 
disease, comorbidities and social needs,
— intensive education on the principles of drug 
treatment and use,
— an individual treatment plan in accordance 
with applicable recommendations, provided 
to the patient, nurse and primary care physi-
cian,
— constant contact with qualified medical per-
sonnel via the Internet.
In 2009, Damps-Konstańska et al. [20] pro-
posed a Polish model of organization of integrated 
care for patients with advanced COPD, including 
hospital and outpatient structures. This mod-
el emphasizes the role of close, multifaceted 
collaboration between lung disease specialists, 
primary care physicians and palliative medicine 
practitioners. They emphasized the important 
role of pulmonary and community nurses, as 
well as psychologists and volunteers, but again, 
exclusively in relation to patients with advanced 
disease — patients with severe COPD (Figure 1). 
They also showed that it is important to create 
standards for appropriate care for patients with 
severe and terminal COPD, which would improve 
the overall quality of life of patients, as well as 
would reduce the frequency of hospitalization 
and costs of medical care [20]. Unfortunately, this 
proposed model of comprehensive care does not 
apply to patients with mild or moderate COPD, 
who, as mentioned earlier, may constitute up to 
80% of cases [4]. They also require the earliest 
possible intervention in the form of multidisci-
plinary, long-term treatment, especially as part 
Figure 1. Integrated care for patients with advanced COPD according to Damps-Konstańska et al. ([15] self modified)
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of outpatient care, personalized rehabilitation, 
in order to inhibit disease progression, prevent 
exacerbations and maintain the optimal quality 
of life [2, 12, 13].
COPD self-management intervention
Disease self-control (the day-to-day actions 
undertaken by the patient) is extremely import-
ant, especially in case of chronic diseases [21, 
22]. The basis for disease self-management in-
terventions is the ability to properly implement 
pro-health behaviors in everyday life, responsi-
bility for therapeutic decisions and improving the 
quality of disease control (reduction of symptoms 
and disease progression) [23, 24]. The sooner it 
is taken, the greater the potential impact on the 
course of the disease. Interventions taken by pa-
tients with chronic obstructive pulmonary disease 
(COPD self-management intervention) include 
not only simple activities, such as learning to use 
inhalers and reading information materials about 
the disease, but also the complex ones, requiring 
the involvement of more people and resources 
[25, 26]. Among them, it is worth mentioning the 
extensive educational programs and training or 
regular support from trained personnel [27, 28].
In 2003, Bourbeau et al. [29] noticed that 
COPD self-management patients who are under 
the systematic care of properly prepared and 
trained healthcare professionals reduce the need 
for medical services and significantly improve 
their health. Their definition of self-management 
was based primarily on the effects of the educa-
tional programs which were introduced earlier. 
In turn, in 2012, Wagg et al. [30] showed that 
the concept of self-management is broader than 
education itself and also includes an action plan, 
symptom observation process, medical manage-
ment, and control of exacerbations.
Lenferink et al. [32] in Cochrane Review com-
pared the effectiveness of COPD self-management 
interventions-based action plans for acute exacer-
bations of COPD with usual care. They also ana-
lyzed respiratory-related hospital admissions and 
other health outcomes. 22 studies that involved 
3,854 participants with COPD were included in 
the study. They concluded that self-management 
interventions were associated with improvements 
in health-related quality of life and lower risk of 
respiratory-related hospital admissions. On the 
other hand, they did not confirm the benefit of 
reduction of respiratory-related mortality rate.
Similarly, Zwerink et al. [33] analyzed the 
efficacy of self-management interventions for 
patients with COPD. They evaluated whether 
self-management interventions in COPD can im-
prove health outcomes or reduce healthcare utili-
zation. Over 3,500 patients were included in the 
study. They also concluded that self-management 
interventions in patients improve health-related 
quality of life and reduce respiratory-related 
hospital admissions. Moreover, self-management 
interventions in patients with COPD improved 
dyspnea measured by the (modified) Medical 
Research Council Scale.
Understanding the current need to precisely 
define the intervention in self-management of 
COPD, Effing et al. in 2016 [17] developed a defi-
nition based on the proposals of an international 
group of experts. The consensus of their sugges-
tions is that interventions in self-management of 
COPD are a personalized element of an often mul-
ticomponent organizational structure that aims to:
— motivating, engaging and supporting patients 
in positively adjusting their health behavior, 
and developing skills to better manage the 
disease;
— optimization and maintenance of physical 
health;
— relieving symptoms and functional impair-
ment in everyday life;
— improving emotional and social well-being 
and quality of life;
— establishing and strengthening contacts be-
tween patients and healthcare professionals, 
family, friends and the community.
The implementation of this process is possi-
ble through repeatable actions between patients 
and health professionals who are competent to 
undertake self-management activities [17]. Pa-
tient-centered activities focus on:
— identifying needs, beliefs about health and 
strengthening internal motivations;
— striving for personalized goals;
— formulating appropriate strategies (e.g., exac-
erbation management) to achieve these goals;
— evaluation and possible readaptation of the 
strategy;
— the use of behavioral change techniques to 
motivate patients and improve their trust and 
competence;
— incorporation of patients’ reading and writing 
skills to increase their comprehension. 
The next step in understanding the role 
of interventions in management, education, as 
well as on-line monitoring of the effects and 
cooperation of patients with stable COPD is the 
understanding of their influence on the clinical 
course and the cost of treatment [33]. The idea 
behind disease self-management programs is to 
Michał Dębczyński et al., Self-management and integrated pulmonary care in COPD treatment
295www.journals.viamedica.pl
help patients manage their symptoms of a stable 
disease on a daily basis, as well as in the event of 
exacerbations. In most cases, these programs are 




b. pulmonary function tests and oximetry;
c. importance of smoking cessation, immu-
nization and pulmonary rehabilitation
2. Smoking cessation counseling:
a. support;
b. goal setting;
c. treatment of tobacco dependence
3. Training in the proper use of inhalers
4. Exercise plans and tips for physical activity
5. Action plans (how to recognize and what to 
do in the event of an exacerbation)
6. Control and management of dyspnea
7. Tips and nutritional goals.
Self-management programs can be dissem-
inated through educational materials and self-
study manuals, or in group sessions, mostly in-
teractive, focused on personalizing goals. Mobile 
devices, such as tablets or phones can help in 
their application. Self-management by reducing 
exposure to risk factors and changing behavior 
can reduce the risk of a COPD exacerbation and 
enable earlier treatment. In turn, the motivational 
interview can also be used to modify the habits of 
COPD patients, which will result in faith in the 
possibility of change [33].
Analysis of studies in which COPD patients 
participated according to the PICO scheme (Pop-
ulation, Interventions, Comparison Outcome) (Ta-
ble 2) in terms of interventions in management, 
education and telemonitoring of effects as well 
as patient cooperation, gave an objective answer 
to the question about the effectiveness and effi-
ciency of actions carried out as part of disease 
self-management [33].
It seems that the implementation of the COPD 
self-management program has a positive effect on: 
quality of life, number of hospitalizations, as well 
as patients’ knowledge of the disease and compli-
ance with medical recommendations. However, it 
does not affect the exacerbation rate [33].
Pulmonary centers
Taking into account the current health needs 
of patients, diagnostic possibilities and  often the 
multicentre location of structures which are es-
sential for the treatment of COPD patients, in our 
opinion, it is necessary to transform the existing 
pulmonary departments, especially in terms of 
expanding their outpatient clinic, into Pulmonary 
Centers. In their structure, in addition to hospital 
departments, i.e. Lung Diseases Ward with ex-
tensive diagnostic facilities, intensive care unit, 
intensive pulmonary supervision units dedicated 
to patients requiring non-invasive mechanical 
ventilation (NIV) the establishment of a Chronic 
Respiratory Failure Treatment Center with am-
bulatory oxygen therapy and NIV and a sleep lab 
included. Pulmonary rehabilitation should be 
expanded to contain components coordinating 
both rehabilitation and educational programs in 
the field of self-management of the disease with 
the widest possible participation of pulmonary 
nurses, physiotherapists, psychologists and ed-
ucators. Extending the scope of services offered 
as part of specialist outpatient care is aimed at 
shifting the main burden of diagnosis and treat-
ment of COPD to the clinic, leaving the need for 
hospitalization only for justified cases. Moreover, 
the efficient functioning of such centers requires 
good, partnership cooperation with primary care 
physicians who have close contact with the pa-
tient and his environment, hence the so-called 
Local Reference Network (Figure 2) [34].
When thinking about the structure of Pul-
monary Centers, it is impossible not to mention 
its two very important  employees: a medical 
coordinator and a pulmonary nurse. The first 
of them, by integrating the work of individual 
departments, workshops or plants, guarantees 
efficient operation, also by transferring time-con-
suming procedures to the responsibilities of as-
sociate professionals, and enables doctors to per-
form purely medical activities [35]. Futhermore, 
new and more advanced specialized pulmonary 
procedures concerning patients with chronic 
respiratory diseases have highlighted the need 
to establish pulmonary nursing specialization as 
soon as possible (Table 3) [20].
Conclusions
Recent years have brought a lot of new data 
about the care of patients with COPD: the di-
agnostic and therapeutic possibilities and the 
approach to treatment of the disease. The Polish 
Respiratory Society has implemented this and 
improved it in some areas. However, there is still 
urgent need for systemic solutions that would 
allow for effective integration into one organism 
of all structures necessary for multidisciplinary 
treatment of patients. These changes would result 
in comprehensive care for all COPD patients, 
regardless of their stage progress and change in 
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Table 2. Effectiveness and efficiency of COPD self-management according to the PICO Strategy (Population, Interventions, 
Comparison, Outcome)
Population Patients with COPD
Interventions Self-management interventions (structured interventions for patients to improve their own health behavior 
and self-management skills)
Self-management plans (e.g., self-defined goals and predetermined plans)
Multicomponent with educational intervention, exercise training and action plan in case of exacerbations
Training to help in self-management
psychological therapy (e.g., cognitive behavioral therapy) targeting COPD-related variables 
(e.g., panic related to shortness of breath)
Telephone applications
Mutual Support Groups
Education (information provided to support wider knowledge of health),
Information leaflets (e.g., on the use of inhalers, lung function)
Structured information sessions
Educational websites/applications
Telemedicine monitoring (data and feedback from healthcare professionals, 
including data on exercise as well as health status)
Comparison Peer comparison
No intervention (placebo, no treatment)
Combination of activities
Outcome Quality of life (SGRQ)
Symptoms, shortness of breath (Borg mMRC and orthopnea scale)
Change in FEV1, rate of change in FEV1
Exercise/physical capacity tolerance (6MWD, SWT)





Knowledge about COPD (Bristol questionnaire)
Adherence to treatment plans
Self-sufficiency (CSES)
Resource use and costs
COPD — chronic obstructive pulmonary disease; CSES — COPD self-efficacy scale; GAD7 — general anxiety disorder-7; HADS — hospital anxiety depression scale; 
mMRC — modified medical research council; PHQ9 — patient health questionnaire-9; SGRQ — St. George’s respiratory questionnaire; SWT — shuttle walking test; 
6MWD — 6 minute walk distance
Figure 2. Proposed model of integrated pulmonary care for the diagnosis and treatment of COPD
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Table 3. Areas of activity of the pulmonary nurse
1. Management of patients with chronic lung diseases leading 
to respiratory failure (COPD, interstitial lung diseases)
2. Functional tests of the respiratory system
3. Endoscopic examination of the respiratory system 
4. Oxygen therapy and NIV
5. Inhalation therapy
6. Obstructive sleep apnea and obesity hypoventilation
COPD — chronic obstructive pulmonary disease; NIV — non-invasive mechan-
ical ventilation
the attitudes of medical staff and patients to the 
disease. Their broadly understood awareness 
and deep commitment, would allow for better 
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